Provectus Biopharmaceuticals, Inc. (PVCT): Net Income
-$5.43M
Year ended 2025-12-31
-$4.75M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$5.43M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$4.73M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$3.10M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$3.55M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$5.54M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$6.68M | n/m | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | -$6.92M | n/m | 2021-03-02, From 2019-01-01 |
| 2018-12-31 | -$8.15M | n/m | 2020-03-05, From 2018-01-01 |
| 2017-12-31 | -$13.52M | n/m | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | -$24.43M | n/m | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | -$24.50M | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$10.24M | n/m | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | -$27.70M | n/m | 2016-03-30, From 2013-01-01 |
| 2012-12-31 | -$12.57M | n/m | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | -$19.43M | n/m | 2014-03-13, From 2011-01-01 |
| 2010-12-31 | -$18.55M | n/m | 2014-03-13, From 2010-01-01 |
| 2009-12-31 | -$12.32M | n/m | 2014-03-13, From 2009-01-01 |
| 2008-12-31 | -$10.27M | n/m | 2014-03-13, From 2008-01-01 |
| 2007-12-31 | -$10.01M | n/m | 2014-03-13, From 2007-01-01 |
| 2006-12-31 | -$8.87M | n/m | 2014-03-13, From 2006-01-01 |
| 2005-12-31 | -$11.76M | n/m | 2014-03-13, From 2005-01-01 |
| 2004-12-31 | -$4.34M | n/m | 2014-03-13, From 2004-01-01 |
| 2003-12-31 | -$3.16M | n/a | 2014-03-13, From 2003-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$5.43M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$11.23M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$10.26M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$7.91M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$9.83M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$12.00M | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | -$41.51M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$1.27M | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | -$41.88M | n/m |
Compare PVCT, ALLR, HIND, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗